Recurring, site-specific chromosomal rearrangements are associated with several human syndromes and malignant disorders. Such nonrandom translocations involving chromosome 22 in band qil are numerous and found to be associated with a diversity ofneoplasms as well as constitutional disorders. Chromosome 11 in bands q23-q24 is similarly involved in several types of tumors as well as in a recurring constitutional reciprocal translocation with chromosome 22. Here we report the use of chromosomal in situ hybridization to compare the translocation breakpoints in the cytologically indistinguishable constitutional t(l1122) and the tumor-related t(l;22) associated with Ewing sarcoma and peripheral neuroepithelioma. We have shown that the breakpoints can be distinguished from each other with iespect to the locus encoding the constant region of the Ig A light chain (Co) at 22q11 and the ETSI locus at 1lq23--q24; ETSI has been called hu-ets-l or human cgets-l. The tumor-associated chromosome 11 breakpoint is also different from those of leukemias with t(9;11) and t(4;11) translocations, Southern-blot analysis showed no rearrangement ofETSI in these disorders in the region detected by our probe. ETSI has also been mapped more precisely to 11q23.3-+q24 by in situ hybridization to cells from an individual with an 11q23.3--qter deletion.Site-specific chromosome rearrangements are associated with both malignant and nonmalignant human disorders. Recurrent rearrangements involving chromosome 22 have been described both in the constitutional karyotype and as acquired somatic abnormalities in neoplastic diseases (1, 2). The breakpoints of the t(9;22) of chronic myelogenous leukemia, the t(9;22) of acute lymphocytic leukemia, and the t(8;22) of Burkitt lymphoma within 22q11 are cytologically indistinguishable. Chromosomal in situ hybridization has been used to map these translocation breakpoints more precisely and has shown that, in fact, the 22q11 breakpoints can be distinguished from each other at a molecular level (3,4).Recently, chromosome 22 has been shown to be involved in a reciprocal translocation with chromosome 11, t(11;22)-(q23-q24;qll-q12) in virtually all cases of swing sarcoma (ES) and peripheral neuroepithelioma (NE) examined cytogenetically (5-10). Askin tumor, a malignancy of the thoracopulmonary region, also has been found recently to have an apparently identical t(11;22) (10) and is likely a neuroepithelioma of the chest wall (11, 12). Recurrent rearrangements involving chromosome 11 at q23-q24 have also been reported in leukemias, including the t(4;11)(q21;q23) of acute lymphoblastic or undifferentiated leukemia (13) and the t(9;11)(q21;q23) of acute monocytic leukemia (14).The 11;22 rearrangement of ES, NE, and Askin tumor is cytologically indistinguishable from the recurrent constitutional chromosomal rearrangement that has been described (1), which involves the same chromosomal regions. The constitutional t(11;22)(q23;q11) is a site-specific, reciprocal translocation that has now been described in more ...